Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development

Go back to Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development
(NASDAQ: ACHV) Delayed: 5.01 -0.09 (1.76%)
Previous Close $5.10    52 Week High
Open $4.98    52 Week Low
Day High $5.16    P/E N/A 
Day Low $4.86    EPS
Volume 2,124,551